It might be hard to believe, but the US FDA, and the CDRH, doesn’t know everything. Very often it all starts with a conversation with the people there. Lots of very helpful people there. I know. Is this an opportunity… Continue Reading
There has been, an ever increasing behind the scenes, push from Pharmacy Benefit Managers, to drive pharmaceutical prices down. Pricing, for the newer Hepatitis C therapeutics, went head to head recently, as two major players didn’t want to be left… Continue Reading
The U.S. began permitting TV ads for prescription drugs in 1997 and is the only country, besides New Zealand, that allows them. Since then, direct-to-consumer ads have boomed, to $5.4 billion in 2005 from $1.2 billion in 1998, according to… Continue Reading
Better explained, than shown on the TV news, or Doctor Talk Shows, is the real science reason for Angelina Jolies’s reason for her surgeries. On the forefront of future Medical Practise is Personalized Medicine. Also referred to as Precsion Medicine.… Continue Reading
Big Pharma Needs to Get Busy in the Lab By Gary Pisano, Mr. Pisano, a professor of business administration at Harvard Business School, is the author of “Science Business: The Promise, the Reality, and the Future of Biotech” (Harvard Business… Continue Reading
Personalized Medicine or Precision Medicine is a medical model that proposes the customization of healthcare – with medical decisions, practices, and/or products being tailored to the individual patient. In this model, diagnostic testing is often employed for selecting appropriate and… Continue Reading
I never would have thought J&J ranked so high. I worked for them, left, and went on my world tour. LOL! From the US, to Scandinavia, through Europe, and Asia. Latin America, the Middle East & Africa have been part… Continue Reading
It is thought that studies involving the use of genome-editing tools to modify the DNA of human embryos will be published shortly. There are grave concerns regarding the ethical and safety implications of this research. There is also fear of… Continue Reading
This post was written by, and reproduced with the permission of Gitte Pedersen. Diagnostics have traditionally been the stepchild of biotech. Why develop a cheap $100 dollar test that a patient will use once compared with a cancer drug that… Continue Reading
Gilead Sciences Inc. said nine patients taking its hepatitis C drugs Harvoni or Sovaldi along with the heart treatment amiodarone developed abnormally slow heartbeats and one died of cardiac arrest. Three required a pacemaker to be inserted. Gilead said in… Continue Reading
March 16, 2015, 8:14 AM|Studies show the new drug slashes bad cholesterol, or “LDL,” by up to 61 percent. It cuts heart attacks and strokes by more than to half. Cardiologist Dr. Tara Narula joins “CBS This Morning” to explain… Continue Reading
CVS Health President and CEO Larry J. Merlo gives an interview on the floor of the New York Stock Exchange September 3, 2014. Credit: Reuters/Brendan McDermid (Reuters) – The entry of copycat biotech drugs (Biosimilars) into the U.S. market could… Continue Reading
Advances in technology are rapidly improving the range of available biotechnological tools and applications. Interfacial opportunities, such as those combining biomedical improvements with aspects of engineering, computing and innovative biomaterials are at the forefront of these enhancements. Personalised and predictive… Continue Reading
Cancer – insidious, family wrenching, a slow torture. Had we had this earlier we could have saved some one that I loved. And, respected. Published on Mar 11, 2015 Duke University released a study Wednesday detailing the results of an… Continue Reading
Will Apple’s Business Model Work In Pharmaceuticals? If you have ever spent time in China – as we have – you will find Cities of Industry leading to dominance in a market sector. Medicine is next. Flip over any Apple… Continue Reading
Those concerned about chemistry’s future in the pharmaceutical industry were undoubtedly alarmed when the French giant Sanofi bragged recently that 72% of its drug discovery and development projects these days are in biologics. Biologics are hot. Sales are growing at… Continue Reading
Medical research is plagued by small sample sizes and inconsistent data collection. So Apple is stepping up to help health innovation with Research Kit, a new iOS software framework that lets people volunteer to join medical research studies. ResearchKit lets… Continue Reading
Google ($GOOG) has given the world a peek at one of the ways in which it thinks algorithms and huge datasets could reshape drug discovery. The work involves trying to make virtual drug screening more efficient using the same ethos… Continue Reading
First Copycat Biotech Drug Spurs $250B Obamacare Savings The first U.S. approval of the “generic” biologic prescription version of the widely prescribed anti-infective cancer medicine Neupogen officially opens the door to a new era in cheaper drugs that could save… Continue Reading
$10 Copy of Gilead Blockbuster Sovaldi Appears in Bangladesh (Bloomberg) — A $10 version of Sovaldi, the Gilead Sciences Inc. hepatitis C treatment that sells for $1,000 a pill in the U.S., is now available in Bangladesh and could make… Continue Reading